Suntrust Banks’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-4,208
Closed -$274K 1305
2017
Q1
$274K Sell
4,208
-6,451
-61% -$380K ﹤0.01% 1072
2016
Q4
$587K Sell
10,659
-64
-0.6% -$3.51K ﹤0.01% 937
2016
Q3
$605K Sell
10,723
-114
-1% -$5.59K ﹤0.01% 901
2016
Q2
$452K Buy
10,837
+5,961
+122% +$275K ﹤0.01% 991
2016
Q1
$208K Sell
4,876
-479
-9% -$20.2K ﹤0.01% 1326
2015
Q4
$242K Buy
+5,355
New +$225K ﹤0.01% 1227

Other funds holding PRAH

Suntrust Banks's PRAH Position: Q2 2017 in Review

Suntrust Banks sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2017, closing a stake of 4,208 shares — an estimated $274K sold.

Suntrust Banks first reported a position in PRAH in Q4 2015 and held it in 6 quarters. The position peaked at $605K in Q3 2016. 235 funds tracked by Wall St. Rank hold PRAH as of Q2 2017.

  • Suntrust Banks reported no remaining PRA Health Sciences, Inc. position as of Q2 2017 after selling out during the quarter.
  • Suntrust Banks sold 4,208 PRA Health Sciences, Inc. shares in Q2 2017, an estimated $274K.
  • Suntrust Banks first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 6 quarters.
  • Suntrust Banks's PRA Health Sciences, Inc. position peaked at $605K in Q3 2016.
  • 235 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2017.

Based on Suntrust Banks's 13F filing for Q2 2017, filed 11 Aug 2017.